| HPFH | hereditary persistence of fetal hemoglobin |
|---|---|
| HPLE | hereditary polymorphic light eruption |
| HPP | hereditary pyropoikilocytosis; history of presenting problems |
| HRA | health record analyst; health risk appraisal; heart rate audiometry; hereditary renal adysplasia; hi... |
| HRC | hereditary renal cancer; high-resolution chromatography; horse red cell; human rights committee |
| ACOG | American College of Obstetricians and Gynecologists |
|---|---|
| ASTM | American Society for Testing and Materials |
| ASTRO | American Society for Therapeutic Radiology and Oncology |
| APUD | Amine Precursor Uptake and Decarboxylation |
| AMPS | Assessment of Motor and Process Skills |
| prostheses and implants | Artificial substitutes for body parts, and materials inserted into tissue for functional, cosmetic, or therapeutic purposes. Prostheses can be functional, as in the case of artificial arms and legs, or cosmetic, as in the case of an artificial eye. Implants, all surgically inserted or grafted into the body, tend to be used therapeutically. Implants, experimental is available for those used experimentally. (12 Dec 1998) |
|---|---|
| prothrombin and proconvertin test | A test formerly used by some to control anticoagulant therapy with bishydroxycoumarin and indandione drugs. Synonym: P and P test. (05 Mar 2000) |
| schizophrenia and disorders with psychotic features | Marked disorders of thought (delusions, hallucinations, or other thought disorder accompanied by disordered affect or behaviour), and deterioration from a previous level of functioning. (12 Dec 1998) |
| protoveratrine A and B | A mixture of two alkaloids isolated from Veratrum album; they exert their main effect upon the cardiovascular system through the carotid sinus receptors and vagal sensory endings in the heart; they cause vasodilation and are thought to bring about a redistribution to all vascular beds and thus to induce a fall in blood pressure; used in certain forms of hypertension; the maleates have the same actions. (05 Mar 2000) |
| psychological phenomena and processes | Mechanisms and underlying psychological principles of mental processes and their applications. (12 Dec 1998) |
| hoof-and-mouth disease | An obsolete term for foot-and-mouth disease. (05 Mar 2000) |
| hormones, hormone substitutes, and hormone antagonists | A collective grouping for both naturally occurring and synthetic hormones, substitutes, and antagonists. (12 Dec 1998) |
| sensitivity and specificity | Measures for assessing the results of diagnostic and screening tests. Sensitivity represents the proportion of truly diseased persons in a screened population who are identified as being diseased by the test. It is a measure of the probability of correctly diagnosing a condition. Specificity is the proportion of truly nondiseased persons who are so identified by the screening test. It is a measure of the probability of correctly identifying a nondiseased person. (12 Dec 1998) |
| hospital design and construction | The architecture, functional design, and construction of hospitals. (12 Dec 1998) |
| Hunter and Driffield curve | Sensitometric curve of radiographic film, a plot of the film density versus the logarithm of the relative exposure. Synonym: H and D curve, Hunter and Driffield curve. (05 Mar 2000) |
| sexual and gender disorders | Mental disorders related to sexual dysfunction, paraphillias, and gender identity disorders. (12 Dec 1998) |
| sheath of Key and Retzius | <anatomy> The delicate bands of connective tissue among nerve fibres. Origin: NL, fr. Gr. Within + a sinew, nerve. Source: Websters Dictionary (01 Mar 1998) |
| hydroxymethyl and formyl transferases | <enzyme> Enzymes that catalyze the transfer of hydroxymethyl or formyl groups. Registry number: EC 2.1.2 (12 Dec 1998) |
| short limbs and osteopenia | <radiology> Osteogenesis imperfecta, hypophosphatasia (12 Dec 1998) |
| signs and symptoms | Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom). (12 Dec 1998) |